Skip to main content
Kara Margolis, MD, Pediatric Gastroenterology, New York, NY

Kara Gross Margolis MD

Pediatric Nutrition


Dorector, NYU Pain Research Center Professor of Molecular Pathobiology, Cell Biology and Pediatrics at NYU Langone, NYU and the NYU College of Dentistry

Join to View Full Profile
  • 433 1st AveNew York, NY 10010

  • Phone+1 212-305-5903

Dr. Margolis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Margolis is a pediatric gastroenterologist and physician-scientist with clinical and scientific expertise in disorders of gut brain interactions (DGBI) and well as GI problems in autistism. She leads translational research programs whose themes center around gut signaling in gut-brain axis conditions, including DGBI, ASD and GI problems and links between abdominal pain and mood disorders.

Education & Training

  • Boston Children’s Hospital//Boston Medical Center
    Boston Children’s Hospital//Boston Medical CenterFellowship, Pediatric Gastroenterology, 2004 - 2007
  • Montefiore Medical Center/Albert Einstein College of Medicine
    Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 2001 - 2004
  • Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo
    Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2001

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2007 - 2026
  • MA State Medical License
    MA State Medical License 2005 - 2008
  • Pediatric Gastroenterology
    American Board of Pediatrics Pediatric Gastroenterology

Publications & Presentations

PubMed

Press Mentions

  • Antidepressants in Pregnancy Linked to Children’s Gut Issues—What’s Known and a Potential Treatment Approach
    Antidepressants in Pregnancy Linked to Children’s Gut Issues—What’s Known and a Potential Treatment ApproachApril 4th, 2025
  • New Study Explores Safer Antidepressants for Pregnant Women
    New Study Explores Safer Antidepressants for Pregnant WomenJanuary 27th, 2025
  • SSRI Antidepressants May Cause Fewer Side Effects When Targeted to the Gut
    SSRI Antidepressants May Cause Fewer Side Effects When Targeted to the GutDecember 12th, 2024
  • Join now to see all

Grant Support

  • Differentiating the roles and underlying mechanisms of serotonin in the gut epithelium and ENS to create a novel drug delivery system to treat disorders of gut-brain interaction and mood dysfunctionNEW YORK UNIVERSITY2024–2029
  • A Prospective Study Examining the Role of Gestational SSRI Exposure in the Development of Functional Gastrointestinal DisordersNEW YORK UNIVERSITY2021–2025
  • Linkage of s100a10 (p11) to enteric 5-HT4-mediated serotonergic signaling roles in GI motility, enteric nervous system development, and co-morbid dysfunction of gut and brainNEW YORK UNIVERSITY2021–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: